Patent ID: 7276050
Filing Date: 2007-10-02
Classification: A61F,A61K

Abstract:
1. A method of treating ocular disorders involving angiogenesis, comprising the steps of: providing a trans-scleral drug delivery device comprising: an insert stabilizer for attachment to a scleral surface and having an interlock opening and an injection port; a removable and refillable implant having a reservoir adjacent the scleral surface and an interlock tab, wherein said insert stabilizer and said removable and refillable implant are removeably connectable by mating said interlock tab and said interlock opening and wherein said injection port communicates with said reservoir; providing an anti-angiogenic factor; refilling said trans-scleral drug delivery device alternately and selectively by disengaging said removable and refillable implant from said insert stabilizer, placing a new dosage of angiogenic factor in a pellet form in said reservoir, and re-interlocking said removable and refillable implant with said insert stabilizer, and injecting a new dosage of angiogenic factor in liquid form in said reservoir through the injection port.